Celltrion, Inc. (KRX:068270)
187,400
+600 (0.32%)
At close: Nov 21, 2025
Celltrion Market Cap
Celltrion has a market cap or net worth of 41 trillion as of November 21, 2025. Its market cap has increased by 6.60% in one year.
Market Cap
41.00T
Enterprise Value
43.08T
Revenue
3.90T
Ranking
n/a
PE Ratio
56.56
Stock Price
187,400.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 41.00T, an increase of 39,400.29%. That is a compound annual growth rate of 41.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 41.00T | 1.58% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | 48.99T | 102.64% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| ALTEOGEN | 29.79T |
| SK Biopharmaceuticals | 9.89T |
| ABL Bio | 9.77T |
| Peptron | 9.00T |
| Yuhan | 8.88T |
| LigaChem Biosciences | 6.47T |
| HLB Co., Ltd. | 6.10T |